arginine has been researched along with candesartan in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (27.27) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 6 (54.55) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Abe, J; Kurokawa, K; Ohno, M; Schwartz, SM; Taguchi, J | 1 |
| Hashimoto, S; Kawata, T; Koike, T | 1 |
| Demeilliers, B; Jover, B; Mimran, A | 1 |
| Imamura, T; Ishikawa, T; Nakayama, K; Nejishima, H | 1 |
| Imai, M; Kumagai, H; Matsuura, T; Onami, T; Osaka, M; Sakata, K; Saruta, T | 1 |
| Aslam, S; Griendling, K; Luo, Z; Teerlink, T; Welch, WJ; Wilcox, CS | 1 |
| Arnesen, H; Bratseth, V; Seljeflot, I; Smith, P; Tveit, A | 1 |
| Banday, AA; Javkhedkar, AA; Lokhandwala, MF | 1 |
1 review(s) available for arginine and candesartan
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for arginine and candesartan
| Article | Year |
|---|---|
L-arginine, asymmetric dimethylarginine and rhythm outcome after electrical cardioversion for atrial fibrillation.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Arginine; Atrial Fibrillation; Benzimidazoles; Biphenyl Compounds; Combined Modality Therapy; Double-Blind Method; Electric Countershock; Female; Humans; Male; Middle Aged; Recurrence; Tetrazoles; Time Factors | 2010 |
9 other study(ies) available for arginine and candesartan
| Article | Year |
|---|---|
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Topical application of AT1 receptor antagonists prevents medial and neointimal proliferation after balloon injury.
Topics: Administration, Oral; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Arginine; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Bromodeoxyuridine; Carotid Artery Diseases; Carotid Artery, Common; Catheterization; Cell Division; Drug Synergism; Imidazoles; Losartan; Male; Muscle, Smooth, Vascular; Rats; Rats, Wistar; Tetrazoles; Tunica Intima; Tunica Media | 1994 |
The angiotensin receptor antagonist 2-ethoxy-1-[[2'-(1H- tetrazol-5-yl) biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylic acid (CV11974) attenuates the tubuloglomerular feedback response during NO synthase blockade in rats.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Arginine; Benzimidazoles; Biphenyl Compounds; Feedback; Hemodynamics; Homeostasis; Kidney Glomerulus; Kidney Tubules; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley; Tetrazoles | 1996 |
Nitric oxide participates in the renal vasodilatory effect of candesartan in anesthetized rats.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Arginine; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Kidney; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Regional Blood Flow; Tetrazoles; Vasodilation | 1999 |
Non-contribution of renin-angiotensin system to pressor response to N(G)-nitro-L-arginine in dogs.
Topics: Animals; Antihypertensive Agents; Arginine; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Bradycardia; Bradykinin; Captopril; Dogs; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Heart Rate; Injections, Intravenous; Male; Nitroarginine; Renin; Renin-Angiotensin System; Stereoisomerism; Tetrazoles | 2002 |
Potentiated sympathetic nervous and renin-angiotensin systems reduce nonlinear correlation between sympathetic activity and blood pressure in conscious spontaneously hypertensive rats.
Topics: Administration, Oral; Angiotensin Receptor Antagonists; Animals; Arginine; Benzimidazoles; Biphenyl Compounds; Blood Flow Velocity; Blood Pressure; Electrocardiography; Heart Rate; Hypertension; Infusions, Intravenous; Kidney; Male; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renin-Angiotensin System; Sympathetic Nervous System; Tetrazoles; Wakefulness | 2002 |
Angiotensin II and NADPH oxidase increase ADMA in vascular smooth muscle cells.
Topics: Analysis of Variance; Angiotensin II; Animals; Arginine; Benzimidazoles; Biphenyl Compounds; Blotting, Western; Cells, Cultured; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; NADPH Oxidases; Rats; Reactive Oxygen Species; Reverse Transcriptase Polymerase Chain Reaction; Tetrazoles | 2010 |
Defective nitric oxide production impairs angiotensin II-induced Na-K-ATPase regulation in spontaneously hypertensive rats.
Topics: Angiotensin II; Animals; Arginine; Benzimidazoles; Biphenyl Compounds; Kidney Tubules, Proximal; Male; NADPH Oxidases; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Sodium-Potassium-Exchanging ATPase; Tetrazoles | 2012 |